Salads, salsas recalled due to Salmonella; Linked to cucumber recall
If you find any of the affected products listed below in your possession, please record the number of cases and destroy the product. Do not return the items.
Consumers, restaurants, retailers, and wholesalers should not eat, sell, or serve the recalled products containing those cucumbers.
If you cannot tell if your products contain cucumbers, do not eat or use them. Throw them away.
The affected products were distributed between May 6, 2025, and May 21, 2025, to multiple customers in Washington D.C., Ohio, Virgina, Michigan, West Virginia, Delaware, Virginia, Maryland, Massachusetts, Pennsylvania, New Jersey, Vermont and North Carolina.
UPC
PACK/SZ
BRAND
DESCRIPTION
ALL LOT CODES
640344010282
1/16 OZ
East Coast Fresh
Fresh Mild Salsa
All Lot Codes
640344012781
1/16 OZ
East Coast Fresh
Fresh Mild Salsa
All Lot Codes
070784034140
1/16 OZ
TOPS
Salsa HOT TOPS (E)
All Lot Codes
070784033846
1/16 OZ
TOPS
Fresh Salsa 1lb CUP
All Lot Codes
888670065808
1/30 OZ
Wellsley Farms
Wellsley Farms Mild Salsa
All Lot Codes
041497075959
1/16 OZ
WEIS
Salsa Mild WEIS
All Lot Codes
688267031953
1/16 OZ
AHOLD
Salsa HOT AHOLD
All Lot Codes
688267032523
1/16 OZ
AHOLD
Salsa 1#-AHOLD
All Lot Codes
640344069624
1/16 OZ
East Coast Fresh
SALSA RETAIL 1# CUP
All Lot Codes
766375251385
1/8 OZ
Jack and Olive
The House Salad
All Lot Codes
766375241973
1/8 OZ
Created Fresh
The House Salad
All Lot Codes
766375737018
1/8 OZ
Spring and Sprout
The House Salad
All Lot Codes
766375241607
1/5.2 OZ
Created Fresh
Mini Garden Salad
All Lot Codes
766375261681
1/5.76 OZ
Created Fresh
Chicken Salad on Everything Fecelle
All Lot Codes
766375261698
1/5.76 OZ
Created Fresh
Egg Salad on Everything Fecelle
All Lot Codes
766375261674
1/5.76 OZ
Created Fresh
Tuna Salad on Everything Fecelle
All Lot Codes
766375253044
1/11.25 OZ
Created Fresh
Southwestern Breakfast Bowl
All Lot Codes
This article originally appeared on Asbury Park Press: FDA recalls salads, salsas due to Salmonella outbreak in cucumbers
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
36 minutes ago
- Business Wire
Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Therapeutics, Inc. ('Vyome'), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced that it has closed the previously disclosed transaction with ReShape Lifesciences Inc. (Nasdaq: RSLS). The post-merger company will trade at the open of trading on Friday, August 15, 2025 under the name Vyome Holdings, Inc. and the trading symbol 'HIND.' About Vyome Vyome is building a healthcare platform spanning the US-India innovation corridor. Based in Cambridge, MA, Vyome's immediate focus is leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. By applying groundbreaking science and its unique positioning across the US-India innovation corridor, Vyome seeks to deliver lasting value to shareholders in a hyper cost-efficient manner while upholding global standards of quality and safety. To learn more, please visit Visit us on social media: Facebook X LinkedIn Forward-Looking Statements Certain statements made in this press release are 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as 'target,' 'believe,' 'expect,' 'will,' 'shall,' 'may,' 'anticipate,' 'estimate,' 'would,' 'positioned,' 'future,' 'forecast,' 'intend,' 'plan,' 'project,' 'outlook', and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Examples of forward-looking statements include, among others, statements made in this report regarding the merger, including the benefits of the merger, revenue opportunities, anticipated future financial and operating performance, and results, including estimates for growth. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management's current beliefs, expectations, and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Vyome's control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results and outcomes to differ materially from those indicated in the forward-looking statements include, among others, the following: (a) the occurrence of any event, change, or other circumstances relating to the combined company; (b) failure to obtain the necessary consents and approvals; (c) the risk that the merger disrupts current plans and operations as a result of the announcement and consummation of the merger; (e) costs related to the merger; and (f) changes in applicable laws or regulations. Vyome cautions that the foregoing list of factors is not exhaustive. Vyome cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Vyome does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, whether as a result of new information, future events, or otherwise, except as may be required by applicable law.
San Francisco Chronicle
36 minutes ago
- San Francisco Chronicle
Ziopharm: Q2 Earnings Snapshot
HOUSTON (AP) — HOUSTON (AP) — Alaunos Therapeutics, Inc. (TCRT) on Thursday reported a loss of $1.1 million in its second quarter. On a per-share basis, the Houston-based company said it had a loss of 63 cents. _____
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
SolarMax Technology: Q2 Earnings Snapshot
RIVERSIDE, Calif. (AP) — RIVERSIDE, Calif. (AP) — SolarMax Technology, Inc. (SMXT) on Thursday reported a loss of $1.9 million in its second quarter. On a per-share basis, the Riverside, California-based company said it had a loss of 4 cents. The solar and renewable energy company posted revenue of $6.9 million in the period. _____
